Humana Inc. (NYSE:HUM) Shares Sold by M&T Bank Corp

M&T Bank Corp cut its holdings in Humana Inc. (NYSE:HUM) by 33.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 7,573 shares of the insurance provider’s stock after selling 3,734 shares during the period. M&T Bank Corp’s holdings in Humana were worth $3,467,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Stratos Wealth Partners LTD. lifted its position in Humana by 4.2% during the third quarter. Stratos Wealth Partners LTD. now owns 1,294 shares of the insurance provider’s stock worth $630,000 after buying an additional 52 shares during the period. Brown Advisory Inc. boosted its position in shares of Humana by 17.3% in the third quarter. Brown Advisory Inc. now owns 2,311 shares of the insurance provider’s stock worth $1,124,000 after acquiring an additional 341 shares during the last quarter. Advisor Partners II LLC grew its holdings in Humana by 9.8% in the third quarter. Advisor Partners II LLC now owns 5,153 shares of the insurance provider’s stock valued at $2,507,000 after purchasing an additional 459 shares during the period. Park Avenue Securities LLC acquired a new position in Humana during the third quarter worth approximately $1,889,000. Finally, Catalyst Financial Partners LLC purchased a new position in Humana during the third quarter worth approximately $209,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In other news, Director Jorge S. Mesquita purchased 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 0.29% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on HUM shares. Argus lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Truist Financial reaffirmed a “hold” rating and set a $550.00 price target on shares of Humana in a research report on Friday, January 19th. Raymond James assumed coverage on Humana in a report on Friday, March 22nd. They set a “market perform” rating on the stock. Barclays decreased their price target on Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. Finally, Cantor Fitzgerald reduced their target price on shares of Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $424.50.

Humana Price Performance

Shares of HUM opened at $324.63 on Wednesday. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm has a market cap of $39.12 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.86 and a beta of 0.49. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $541.21. The stock has a 50 day moving average of $323.08 and a 200-day moving average of $385.94.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the previous year, the firm earned $9.38 earnings per share. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. As a group, analysts forecast that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.09%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.